LIXT
Price
$1.19
Change
-$0.04 (-3.28%)
Updated
Apr 3 closing price
Capitalization
3.18M
PMN
Price
$0.64
Change
-$0.07 (-9.86%)
Updated
Apr 3 closing price
Capitalization
20.92M
46 days until earnings call
Ad is loading...

LIXT vs PMN

Header iconLIXT vs PMN Comparison
Open Charts LIXT vs PMNBanner chart's image
Lixte Biotechnology Holdings
Price$1.19
Change-$0.04 (-3.28%)
Volume$3.45K
Capitalization3.18M
ProMIS Neurosciences
Price$0.64
Change-$0.07 (-9.86%)
Volume$35.2K
Capitalization20.92M
LIXT vs PMN Comparison Chart
Loading...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIXT vs. PMN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIXT is a StrongBuy and PMN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (LIXT: $1.18 vs. PMN: $0.64)
Brand notoriety: LIXT and PMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIXT: 4% vs. PMN: 91%
Market capitalization -- LIXT: $3.18M vs. PMN: $20.92M
LIXT [@Biotechnology] is valued at $3.18M. PMN’s [@Biotechnology] market capitalization is $20.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIXT’s FA Score shows that 0 FA rating(s) are green whilePMN’s FA Score has 0 green FA rating(s).

  • LIXT’s FA Score: 0 green, 5 red.
  • PMN’s FA Score: 0 green, 5 red.
According to our system of comparison, PMN is a better buy in the long-term than LIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIXT’s TA Score shows that 5 TA indicator(s) are bullish while PMN’s TA Score has 6 bullish TA indicator(s).

  • LIXT’s TA Score: 5 bullish, 4 bearish.
  • PMN’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, PMN is a better buy in the short-term than LIXT.

Price Growth

LIXT (@Biotechnology) experienced а -5.21% price change this week, while PMN (@Biotechnology) price change was -8.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

LIXT is expected to report earnings on May 10, 2023.

PMN is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMN($20.9M) has a higher market cap than LIXT($3.18M). PMN YTD gains are higher at: -32.465 vs. LIXT (-41.617). PMN has higher annual earnings (EBITDA): -391.76K vs. LIXT (-3.98M). PMN has more cash in the bank: 21.6M vs. LIXT (1.64M). LIXT has less debt than PMN: LIXT (100K) vs PMN (4.05M). LIXT (0) and PMN (0) have equivalent revenues.
LIXTPMNLIXT / PMN
Capitalization3.18M20.9M15%
EBITDA-3.98M-391.76K1,015%
Gain YTD-41.617-32.465128%
P/E RatioN/A6.46-
Revenue00-
Total Cash1.64M21.6M8%
Total Debt100K4.05M2%
FUNDAMENTALS RATINGS
LIXT vs PMN: Fundamental Ratings
LIXT
PMN
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIXT's Valuation (72) in the null industry is in the same range as PMN (95). This means that LIXT’s stock grew similarly to PMN’s over the last 12 months.

LIXT's Profit vs Risk Rating (100) in the null industry is in the same range as PMN (100). This means that LIXT’s stock grew similarly to PMN’s over the last 12 months.

PMN's SMR Rating (92) in the null industry is in the same range as LIXT (100). This means that PMN’s stock grew similarly to LIXT’s over the last 12 months.

PMN's Price Growth Rating (65) in the null industry is in the same range as LIXT (65). This means that PMN’s stock grew similarly to LIXT’s over the last 12 months.

PMN's P/E Growth Rating (98) in the null industry is in the same range as LIXT (100). This means that PMN’s stock grew similarly to LIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIXTPMN
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
LIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDR15.940.75
+4.94%
Idaho Strategic Resources
MTX58.56-4.50
-7.14%
Minerals Technologies
SGBX0.42-0.04
-8.59%
Safe & Green Holdings Corp.
SNCY10.90-1.37
-11.17%
Sun Country Airlines Holdings
TPR65.09-9.65
-12.91%
Tapestry

LIXT and

Correlation & Price change

A.I.dvisor tells us that LIXT and NTLA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIXT and NTLA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-2.87%
NTLA - LIXT
28%
Poorly correlated
-5.62%
IBIO - LIXT
28%
Poorly correlated
-7.77%
BBIO - LIXT
27%
Poorly correlated
-1.59%
PMN - LIXT
26%
Poorly correlated
-9.96%
ITOS - LIXT
26%
Poorly correlated
-1.21%
More

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-9.96%
SYRE - PMN
44%
Loosely correlated
-9.68%
BBIO - PMN
42%
Loosely correlated
-1.59%
ABOS - PMN
33%
Poorly correlated
-8.52%
LIXT - PMN
27%
Poorly correlated
-2.87%
ARGX - PMN
25%
Poorly correlated
+1.10%
More